Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2024
2024
Historique:
received:
10
04
2023
accepted:
26
03
2024
medline:
11
4
2024
pubmed:
11
4
2024
entrez:
11
4
2024
Statut:
epublish
Résumé
In Neurofibromatosis type 1 (NF1), peripheral nerve sheaths tumors are common, with cutaneous neurofibromas resulting in significant aesthetic, painful and functional problems requiring surgical removal. To date, determination of adequate surgical resection margins-complete tumor removal while attempting to preserve viable tissue-remains largely subjective. Thus, residual tumor extension beyond surgical margins or recurrence of the disease may frequently be observed. Here, we introduce Shifted-Excitation Raman Spectroscopy in combination with deep neural networks for the future perspective of objective, real-time diagnosis, and guided surgical ablation. The obtained results are validated through established histological methods. In this study, we evaluated the discrimination between cutaneous neurofibroma (n = 9) and adjacent physiological tissues (n = 25) in 34 surgical pathological specimens ex vivo at a total of 82 distinct measurement loci. Based on a convolutional neural network (U-Net), the mean raw Raman spectra (n = 8,200) were processed and refined, and afterwards the spectral peaks were assigned to their respective molecular origin. Principal component and linear discriminant analysis was used to discriminate cutaneous neurofibromas from physiological tissues with a sensitivity of 100%, specificity of 97.3%, and overall classification accuracy of 97.6%. The results enable the presented optical, non-invasive technique in combination with artificial intelligence as a promising candidate to ameliorate both, diagnosis and treatment of patients affected by cutaneous neurofibroma and NF1.
Identifiants
pubmed: 38603731
doi: 10.1371/journal.pone.0302017
pii: PONE-D-23-09081
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0302017Informations de copyright
Copyright: © 2024 Matthies et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pathology. 2014 Feb;46(2):95-104
pubmed: 24378391
J Pediatr Surg. 2008 Jan;43(1):171-6
pubmed: 18206477
Anal Chem. 2022 Jan 25;94(3):1575-1584
pubmed: 35015512
Lancet Oncol. 2011 Oct;12(11):997-1003
pubmed: 21868284
Biomed Opt Express. 2011 Mar 18;2(4):915-26
pubmed: 21483613
Neuro Oncol. 2022 Oct 3;24(10):1790-1798
pubmed: 35426432
Lancet Oncol. 2006 May;7(5):392-401
pubmed: 16648043
Biomed Opt Express. 2014 Aug 28;5(9):3252-65
pubmed: 25401036
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 29117388
BJU Int. 2015 Sep;116(3):478-86
pubmed: 25124551
Clin Sarcoma Res. 2012 Oct 04;2(1):17
pubmed: 23036231
Nat Protoc. 2016 Apr;11(4):664-87
pubmed: 26963630
J Biomed Opt. 2018 Nov;23(11):1-6
pubmed: 30499261
Nat Rev Dis Primers. 2017 Feb 23;3:17004
pubmed: 28230061
Acta Neuropathol. 2012 Mar;123(3):295-319
pubmed: 22327363
Analyst. 2013 Oct 7;138(19):5639-46
pubmed: 23905163
Genes Chromosomes Cancer. 1999 Mar;24(3):283-5
pubmed: 10451710
Sci Rep. 2017 Oct 25;7(1):13995
pubmed: 29070870
Int J Oncol. 2003 Sep;23(3):649-55
pubmed: 12888900
Sci Rep. 2018 Jul 30;8(1):11410
pubmed: 30061592
Anal Chim Acta. 2020 Dec 1;1139:111-118
pubmed: 33190693
J Pediatr Surg. 2009 Feb;44(2):386-91
pubmed: 19231540
Cancer Genet Cytogenet. 1999 Aug;113(1):65-9
pubmed: 10459349
PLoS One. 2014 Feb 06;9(2):e85954
pubmed: 24516522
PLoS One. 2016 Jul 25;11(7):e0158083
pubmed: 27455410
Spectrochim Acta A Mol Biomol Spectrosc. 2005 May;61(7):1529-35
pubmed: 15820887
Appl Spectrosc. 2003 Nov;57(11):1363-7
pubmed: 14658149
Anal Chem. 2018 Apr 3;90(7):4832-4839
pubmed: 29513001
Sci Rep. 2017 Apr 12;7(1):845
pubmed: 28405007
Exp Dermatol. 2022 Sep;31(9):1311-1329
pubmed: 35837832
Lancet Oncol. 2017 Feb;18(2):e69
pubmed: 28089105
Appl Opt. 2015 Jun 10;54(17):5520-4
pubmed: 26192855
J Neurooncol. 2021 Feb;151(3):393-402
pubmed: 33611706
Anticancer Res. 2022 Mar;42(3):1247-1261
pubmed: 35220215
Histochem Cell Biol. 2013 Jan;139(1):181-93
pubmed: 22892663
IEEE Trans Biomed Eng. 2004 Oct;51(10):1784-93
pubmed: 15490825
World J Nucl Med. 2019 Jan-Mar;18(1):66-68
pubmed: 30774551
Exp Dermatol. 2021 May;30(5):652-663
pubmed: 33566431
Sci Rep. 2020 Jul 8;10(1):11215
pubmed: 32641779
Analyst. 2012 Jan 21;137(2):322-32
pubmed: 22114757
Dtsch Arztebl Int. 2020 May 15;117(20):354-360
pubmed: 32657748
Microsc Res Tech. 2005 Oct;68(2):75-9
pubmed: 16228983
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818782532
pubmed: 29991340
J Biomed Opt. 2012 Nov;17(11):116021
pubmed: 23154776
Biomed Opt Express. 2010 Aug 19;1(2):617-626
pubmed: 21258495
PLoS One. 2014 Apr 07;9(4):e93906
pubmed: 24710050
Exp Dermatol. 2017 Jul;26(7):645-648
pubmed: 27622733
Nat Med. 2020 Jan;26(1):52-58
pubmed: 31907460
Biomed Opt Express. 2021 Jan 13;12(2):836-851
pubmed: 33680545
J Endourol. 2009 May;23(5):861-7
pubmed: 19425823
Ann N Y Acad Sci. 1986;486:260-70
pubmed: 3105391
J Biomed Opt. 2013 Nov;18(11):116011
pubmed: 24281358
Nat Biotechnol. 2011 Apr;29(4):352-6
pubmed: 21297616
Neuro Oncol. 2022 Nov 2;24(11):1827-1844
pubmed: 35657359
Hum Mutat. 2008 Aug;29(8):E103-11
pubmed: 18484666
Curr Opin Neurol. 2002 Dec;15(6):679-84
pubmed: 12447105
Nat Genet. 1993 Feb;3(2):122-6
pubmed: 8499945
Analyst. 2015 Jan 7;140(1):250-7
pubmed: 25382860
Biomed Opt Express. 2015 May 08;6(6):2022-35
pubmed: 26114026
PLoS One. 2019 Feb 14;14(2):e0212376
pubmed: 30763392
Sensors (Basel). 2020 Nov 24;20(23):
pubmed: 33255459
Mod Pathol. 1998 Jul;11(7):612-7
pubmed: 9688181